CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Actelion AG Company Snapshot
Actelion AG operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Actelion AG with three other miscellaneous service companies in Europe: Genus plc of the United Kingdom (2015 sales of £398.50 million [US$486.57 million] of which 44% was Genus PIC), ICON plc of Ireland (1.43 billion Euro [US$1.51 billion] ), and Eurofins Scientific SE (French Branch) which is based in France (1.95 billion Euro [US$2.06 billion] of which 100% was Analytics Services).

Sales Analysis. Actelion AG reported sales of 2.05 billion Swiss Francs (US$2.02 billion) for the year ending December of 2015. This represents an increase of 4.5% versus 2014, when the company's sales were 1.96 billion Swiss Francs. This was the third consecutive year of growth at Actelion AG. The sales level in 2015 was fairly close to the level five years ago: in 2010, Actelion AG had sales of 1.93 billion Swiss Francs.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Actelion AG
  Stock Performance Chart for Actelion AG
 
  Stock Data: Recent Stock Performance:
  Current Price (1/13/2017): 231.30
(Figures in Swiss Francs)
1 Week 1.3%   13 Weeks 6.0%  
4 Weeks 44.7%   52 Weeks 83.6%  
 
Actelion AG Key Data:
  Ticker: ATLN Country: Switzerland
  Exchanges: GVA OTH Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Commercial Physical Research
  2015 Sales 2,045,062,000
(Year Ending Jan 2016).
Employees: 2,396
  Currency: Swiss Francs Market Cap: 23,976,194,165
  Fiscal Yr Ends: December Shares Outstanding: 103,658,427
  Share Type: Namenaktie Closely Held Shares: 9,274,713
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.